← Back to Search

Cognitive-behavioral skills building intervention

Mental Health Resiliency Intervention for Suicide Prevention in Nurses

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4)
Awards & highlights

Study Summary

This trial will test an intervention to prevent nurse suicide. Nurses will be recruited nationally and tested with a screening & skills building program.

Who is the study for?
This trial is for registered nurses who are at moderate to high risk of suicide, as identified by the HEAR-specific interactive screening program. Nurses must self-identify as such and be recognized nationally through the American Nurses Association.Check my eligibility
What is being tested?
The study is testing two approaches: one group will use the HEAR program alone, which screens and refers clinicians for treatment anonymously online; another group will combine HEAR with MINDBODYSTRONG©, a cognitive-behavioral intervention with eight sessions designed to reduce depression and suicidal thoughts.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort or distress while discussing sensitive topics during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in is being assessed for an increase or decrease in self-reported depressive symptoms
Suicide
Secondary outcome measures
Change in being assessed for an increase or decrease in self-reported anxiety symptoms
Change is being assessed for an increase or decrease in self-reported burnout level
Change is being assessed for an increase or decrease in self-reported healthy lifestyle behaviors
+5 more

Trial Design

2Treatment groups
Active Control
Group I: HEARActive Control1 Intervention
Participants who are identified as having moderate to high risk of suicide, as identified by suicide risk on the ISP, will be contacted by a mental health counselor who will engage them through the HEAR encrypted interface online. The mental health counselor will offer counseling online through encryption or on the phone. Where indicated, the mental health counselor will provide the crisis hotline, and encourage participants to use their insurance provider and/or Employee Assistance Program to obtain treatment. The mental health counselor will offer to help with referrals and will bridge high-risk participants into treatment. Participants who are not identified as having moderate to high risk of suicide will be thanked for their time.
Group II: HEAR plus MINDSTRONGActive Control1 Intervention
Participants identified as having a moderate to high risk of suicide based on ISP screening will then be randomized. Participants randomized to the MINDBODYSTRONG© program (intervention) will receive the 8-session online interactive program. Reminders will be sent weekly to complete the next MINDBODYSTRONG© session and a MINDBODYSTRONG© trained coach will check in with participants by phone at baseline, weeks 3 and 5 of the on-line program to reinforce key program concepts and assess whether participants are completing the weekly skills building activities. Nurses assigned to the control group will only receive the HEAR program alone (aforementioned) and will be contacted for follow-up surveys.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
823 Previous Clinical Trials
496,043 Total Patients Enrolled
13 Trials studying Depression
3,317 Patients Enrolled for Depression
American Foundation for Suicide PreventionOTHER
32 Previous Clinical Trials
4,529 Total Patients Enrolled
9 Trials studying Depression
652 Patients Enrolled for Depression
University of San DiegoOTHER
4 Previous Clinical Trials
5,739 Total Patients Enrolled

Media Library

MINDBODYSTRONG™ (Cognitive-behavioral skills building intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05582343 — N/A
Depression Research Study Groups: HEAR, HEAR plus MINDSTRONG
Depression Clinical Trial 2023: MINDBODYSTRONG™ Highlights & Side Effects. Trial Name: NCT05582343 — N/A
MINDBODYSTRONG™ (Cognitive-behavioral skills building intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05582343 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research protocol currently open for enrollment?

"Indeed, clinicaltrials.gov states that this medical research is open for recruitment in the current moment. It was first posted on April 17th 2023 and has most recently been updated on May 12th 2023 with a call for 5200 participants from one single site."

Answered by AI

How many people have chosen to partake in this experiment thus far?

"Affirmative. Information found on clinicaltrials.gov confirms that recruitment is underway for this study, which was initially posted on April 17th 2023 and subsequently updated the following month. The investigation requires 5200 participants to be enrolled from one medical facility."

Answered by AI

What are the primary goals of this research endeavor?

"This clinical trial has a timeline of Baseline (Timepoint 0), 8 weeks after baseline (Timepoint 1), 3 months after screening (Timepoint 2), 6 months after screening (Timepoint 3) and 12 months after screening (Timepoint 4). The primary objective is to evaluate the impact on self-reported depressive symptoms. Secondary objectives include an assessment of changes in anxiety levels, post-traumatic stress levels, and job satisfaction. Anxiety will be measured using the Generalized Anxiety Disorder Scale while PTSD will be evaluated via Primary Care's PTSD Screen for DSM-5 tool. Job Satisfaction will be determined by administering the Job Satisfaction Scale"

Answered by AI
~3228 spots leftby Oct 2025